Identification and Targeting of Therapeutic Resistance Mechanisms in Inflammatory Breast Cancer
<p>Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer that is characterized by survival signaling through overexpression and/or activation of the epidermal growth factor receptors EGFR/ErbB1 and Her2/ErbB2 and defects in the apoptotic program. The developmen...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10161/8087 |